Categories
-Top News Asia News

Pakistan Struggles to Stem Covid Surge

Britain has imposed new travel restrictions on travel from Pakistan. From this Friday onwards (9th April), the passengers from Pakistan will go undergo a self-funded hotel quarantine. The poor vaccination drive is causing troubles for Pakistanis. Lagging behind others in South Asia and slow in its launch, Pakistan’s drive to vaccinate its people against Covid-19 continues to send clear signs of confusion. As a result, just 0.8 million people from a 20 million population have been vaccinated by the end of March. And this is not surprising, experts, concerned at the delay, at home and abroad note …. Writes Dr Amanulla Khan

Covid is dogging everybody in Pakistan. Just after the Prime Minister, the President also tested positive on Covid-19 last month. It may not seem unusual, but that they got infected after being administered first dose of the Chinese-produced Sinopharm vaccine, has caused concern.

For one, it has injected an element of distrust among the population that is awaiting the vaccine as the country experiences its second wave of the pandemic.

Zafar Mirza, a former Special Assistant to Prime Minister Imran Khan on health, has pointed out that Pakistan was one of the trial sites for this vaccine but did not insist for a right to access these vaccines once they were produced and approved.

“This was the first such trial in Pakistan. This anomaly should not be repeated with future trials. Our population should not act as guinea pigs, but instead receive a guaranteed fair share from the manufacturers once the trial is complete.”

Pakistan Prime Minister Imran Khan

Lagging behind others in South Asia and slow in its launch, Pakistan’s drive to vaccinate its people against Covid-19 continues to send clear signs of confusion.

As a result, just 0.8 million people from a 20 million population have been vaccinated by the end of March. And this is not surprising, experts, concerned at the delay, at home and abroad note.

The first batch of vaccines containing 0.5 million vaccines arrived in Pakistan on February 1 from China.

Also read:Public gatherings banned in Pakistan

The process started slowly as there were no takers for the Chinese coronavirus vaccine. Many healthcare workers refused to register themselves for the vaccine, expressing concerns regarding the safety or efficacy of the vaccine, officials and experts told Al Jazeera.

Pakistan’s dilemma is manifold. Many in overwhelmingly Muslim nation do not trust a vaccine. The clergy rant against it from microphones at mosques every Friday. Vaccine, any vaccine, could render you impotent, they warn. There is a sordid record of attacks, even killing, of health volunteers who administer polio vaccine. Along with the neighbouring Afghanistan, Pakistan remains among the few nations where polio persists.

A handover ceremony is held for the second batch of COVID-19 vaccines donated by the Chinese government at Noor Khan Air Base near Islamabad, capital of Pakistan

The clergy and the conservatives warn how Osama bin Laden was located and killed in 2011 when a doctor who gathered data for vaccine ‘betrayed’ by passing it on to the Americans.

When it comes to vaccine against Covid-19, there are other aspects of distrust. The government does not trust AstraZeneca that is British-developed, because it is Indian-produced.

Also read:Pakistan blocks TikTok again

The adversarial India may send vials with water filled in, goes the rumour campaign. Till mid-March, the government had not placed any orders, the National Assembly was informed.

People wearing face masks walk on a road in Rawalpindi of Pakistan’s Punjab province

The prime Minister attacked the ‘rich’ and appealed to the world community to help the ‘poorer’ nations meet this urgency. Pakistan kept waiting for GAVI, the global alliance that is engaged in pooling the vaccines to distribute it among the poor nations.

Finally, when orders were placed, they were for either purchase or free supply of the Chinese vaccine that was slow in being cleared for safety and efficacy than the British and the others. Doubts persist and now the public does not trust the vaccine coming from the “all weather friend.”

Conventional medical wisdom about vaccination is that there has got to be some ‘reaction’ or side-effects, like mild fever, that actually indicate that the vaccine is working on the body injected. But the president and the prime minister, by invoking God Almighty and seeming helpless, betrayed both, lack of knowledge and of faith.

Pakistan PM takes vaccine(IANS)
Also read:Social media war between B’desh and Pakistan

President Arif Alvi took this further by saying that he was hoping to get cured after the second dose, again casting doubts about the first one.

Issuing a clarification on Khan’s vaccination, the Ministry of National Health Services, Regulations and Coordination said that antibodies develop two to three weeks after the 2nd dose of the 2-dose COVID-19 vaccines.

“Prime Minister Imran Khan was not fully vaccinated when he contracted the virus. He only got the 1st dose and merely 2 days ago which is too soon for ANY vaccine to become effective. Anti-bodies develop 2-3 weeks after the 2nd dose of COVID vaccines,” it said on Twitter.

By contrast, Indian Prime Minister Narendra Modi let it be known that he did not even realise when the jab was administered, to boost public confidence and trust. He extended his best wishes to his Pakistani counterpart for a speedy recovery from COVID-19.

Writing in Dawn, Zafar Mirza warns the government on the need to take the public into confidence. “Citizens have questions and misconceptions regarding the vaccines. It is imperative that these concerns are proactively addressed and not permitted to spread unabated.”

Also read:US report highlights arbitrary killings, kidnappings in Pakistan

Categories
-Top News UK News

UK to try out ‘Covid status certification’

The National Health Service (NHS) will set up a system that will allow people to use an app or a paper certificate to gain access to major events..reports Asian Lite News

UK Prime Minister Boris Johnson is expected to unveil plans on Monday to develop a “Covid status certification” scheme to enable the safe return of mass gatherings and indoor events as lockdown restrictions eased in England.

Football cup finals, the World Snooker Championship, a comedy club and a cinema will be used to test vaccine passports over the next few weeks, Xinhua news agency quoted a report by the Guardian newspaper.

The evidence from the trials will be used to consider the wider use of vaccine passports, it said.

According to the newspaper, the National Health Service (NHS) will set up a system that will allow people to use an app or a paper certificate to gain access to major events.

The system being piloted will take into consideration whether someone has had a vaccination, a recent negative test, or natural immunity after a positive test in the last six months, said the newspaper.

Johnson will set out more details on Monday at a time when his government announced that more than 5 million people in Britain have received their second dose of the vaccine.

UK

However, British lawmakers will want to study the proposals closely with many deeply suspicious about anything which smacks of a “vaccine passport” for domestic use, the Evening Standard newspaper reported.

More than 40 Conservative lawmakers have publicly declared their opposition to the idea, and Johnson could struggle to get the plan through the British Parliament if they decide to oppose it, said the London-based newspaper.

Also read:UK PM’s race adviser steps down

In developing the scheme, officials will take into account three factors, whether an individual has received the vaccine, has recently tested negative for the virus, or has “natural immunity” having tested positive in the previous six months.

The Prime Minister will also outline the government’s approach for easing restrictions on foreign travel when its global travel task force reports on April 12.

British ministers have made it clear that the ban on foreign travel will remain in place until at least May 17.

When it is finally lifted, it will be replaced by a risk-based “traffic light” system with red, amber and green ratings for countries around the world, local media reported.

Also read:UK mulls Covid vax certification

This will be based on a range of factors, including the proportion of the population that has been vaccinated, rates of infection, emerging new variants and the country’s access to reliable scientific data and genomic sequencing.

Travellers arriving from countries rated “green” will not be required to isolate, although pre-departure and post-arrival tests will still be needed.

For those classed as “amber” or “red”, the restrictions will remain as they are will arrivals required to isolate or enter quarantine.

UK starts surge testing

More than 31.4 million people have been given the first jab of the coronavirus vaccine, according to the official figures.

From April 12, non-essential retail, as well as restaurants and pubs, if serving people outdoors, will be allowed to reopen in England.

On February 22, Johnson had announced his roadmap exiting the lockdown, the third of its kind since the start of the pandemic.

The four-step plan is expected to see all legal restrictions in England being removed by mid-June.

Experts have warned the UK is “still not out of the woods” amid concerns over new variants and the third wave of pandemic in the European continent.

Also read:UK confirms 7 blood clot deaths linked to AstraZeneca

Categories
-Top News World News

CDC reveals Pfizer, Moderna jabs effective in real world

It takes about two weeks following each dose of vaccine for the body to produce antibodies that protect against infection…reports Asian Lite News.

Pfizer-BioNTech and Moderna’s Covid-19 vaccines are highly effective in preventing infections in real world conditions, says a new study by the US Centers for Disease Control and Prevention (CDC).

Results showed that following the second dose of vaccine, risk of infection was reduced by 90 per cent two or more weeks after vaccination, the CDC said on Monday.

Following a single dose of either vaccine, the participants’ risk of infection with SARS-CoV-2 was reduced by 80 per cent two or more weeks after vaccination.

The study looked at the effectiveness of Pfizer-BioNTech and Moderna mRNA vaccines in preventing SARS-CoV-2 infections among nearly 4,000 participants in six US states over a 13-week period from December 14, 2020 to March 13, 2021.

It takes about two weeks following each dose of vaccine for the body to produce antibodies that protect against infection.

As a result, people are considered “partially vaccinated” two weeks after their first dose of mRNA (Messenger RNA) vaccine and “fully vaccinated” two weeks after their second dose.

These new vaccine effectiveness findings are consistent with those from phase-3 clinical trials conducted with the vaccines before they received Emergency Use Authorisations from the US Food and Drug Administration (FDA).

Those clinical trials evaluated vaccine efficacy against Covid-19 disease, while this study evaluated vaccine effectiveness against infection, including infections that did not result in symptoms.

Zulema Riquelme, a 46-year-old nursing technician, receives a shot of the COVID-19 vaccine at the Metropolitan Hospital in Santiago, Chile

“This study shows that our national vaccination efforts are working. The authorised mRNA Covid-19 vaccines provided early, substantial real-world protection against infection for our nation’s health care personnel, first responders, and other frontline essential workers,” CDC Director Rochelle Walensky, said in a statement.

This study also provided positive news about partial (one-dose) vaccination.

The estimate of 80 per cent effectiveness in this study is consistent with other recent studies following the first dose of Pfizer-BioNTech vaccine among health care providers.

children walking in street during Covid 19 surge in us

Studies conducted in the UK and Israel showed that one dose was about 70 per cent and 60 per cent effective, respectively, against SARS-CoV-2 infection.

The current results provide reassurance that people start to develop protection from the vaccine two weeks after their first dose.

The greatest protection was seen among those who had received both recommended doses of the vaccine.

Also Read-UAE begins Covid-19 vaccine production

Read More-Germany limits use of AstraZeneca jabs